The DOI matches its Crossref record; 200 of the 201 references it cites were found in a registry or an index.
Pleiotropic Effects of Statins on the Cardiovascular System
Open accessAbstract
The statins have been used for 30 years to prevent coronary artery disease and stroke. Their primary mechanism of action is the lowering of serum cholesterol through inhibiting hepatic cholesterol biosynthesis thereby upregulating the hepatic low-density lipoprotein (LDL) receptors and increasing the clearance of LDL-cholesterol. Statins may exert cardiovascular protective effects that are independent of LDL-cholesterol lowering called pleiotropic effects. Because statins inhibit the production of isoprenoid intermediates in the cholesterol biosynthetic pathway, the post-translational prenylation of small GTP-binding proteins such as Rho and Rac, and their downstream effectors such as Rho kinase and nicotinamide adenine dinucleotide phosphate oxidases are also inhibited. In cell culture and animal studies, these effects alter the expression of endothelial nitric oxide synthase, the stability of atherosclerotic plaques, the production of proinflammatory cytokines and reactive oxygen species, the reactivity of platelets, and the development of cardiac hypertrophy and fibrosis. The relative contributions of statin pleiotropy to clinical outcomes, however, remain a matter of debate and are hard to quantify because the degree of isoprenoid inhibition by statins correlates to some extent with the amount of LDL-cholesterol reduction. This review examines some of the currently proposed molecular mechanisms for statin pleiotropy and discusses whether they could have any clinical relevance in cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Beyond the modification of blood lipid levels, in vitro and in vivo studies showed that statins exert beneficial cardioprotective pleiotropic effects [35, 36].”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Preoperative statin therapy for patients undergoing cardiac surgery
Liakopoulos, O. J., Kuhn, E. W., Slottosch, I., Wassmer, G., & Wahlers, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008493.pub2 · Cited by 145
RetractedPreoperative statin therapy for patients undergoing cardiac surgery
Kuhn, E. W., Slottosch, I., Wahlers, T., & Liakopoulos, O. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008493.pub3 · Cited by 53
RetractedPreoperative statin therapy for patients undergoing cardiac surgery
Kuhn, E. W., Slottosch, I., Wahlers, T., & Liakopoulos, O. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008493.pub4 · Cited by 21
RetractedOLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Research works printed but not linked: 1
- 10.1056/NEJM199811053391902 · DOI · Paper page
Cited by
Sorted by citations
Items 901–999 of 999
Söylemez, N., Ballı, M., KÖKSAL, F., Yılmaz, M., Sag, F. E., Tekin, E. E., Yeşiltaş, M. A., Vezir, Ö., Aydınlı, B., & Özkan, B. (2021) · The Heart Surgery Forum · doi:10.1532/hsf.3837 · Cited by 2
Mirbolouk, F., Salari, A., Tirani, H., Moayerifar, M., Gholipour, M., & Sheikhi, M. (2020) · Immunopathologia Persa · doi:10.34172/ipp.2021.15 · Cited by 2
Exploring the Role of Statins in Reversing the Cognitive and Neurovascular Dysfunctions in Dementia
Singh, M., Agarwal, V., Pancham, P., Agarwal, S., Bhardwaj, S., & Mani, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_15 · Cited by 2
Contigli, C., Valle, M. S., Oloris, S. C. S., Pimenta, L. P. S., & Takahashi, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-18587-8_17 · Cited by 2
Effects of Simvastatin on RBL-2H3 Cell Degranulation
Yoshii, M., Kitazaki, A., & Ozawa, K. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00591 · Cited by 2
Chang, H.-H., Liu, W.-C., & Tsai, T. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03681-3 · Cited by 2
Zaryczańska, K., Pawlukowska, W., Nowacki, P., Zwarzany, Ł., Bagińska, E., Kot, M., & Masztalewicz, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206608 · Cited by 2
Likozar, A. R., Ugovšek, S., & Šebeštjen, M. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176232 · Cited by 4
Statins, Inflammation, and Tissue Context in REPRIEVE
Feinstein, M. J. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2023.5671 · Cited by 2
de Liyis, B. G., Jagannatha, G. N. P., Kosasih, A. M., Darma, I. K. S. S., & Artha, I. M. J. R. (2024) · The Egyptian Heart Journal · doi:10.1186/s43044-024-00481-7 · Cited by 2
Сароян, К. В., SYTNIK, I. N., Soldatov, V. O., Pershina, M. A., Жернакова, Н. И., Povetkin, S. V., & SERNOV, L. N. (2018) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2018-25-4-124-131 · Cited by 2
Yuan, H., Wang, D., Zhang, Y., & Geng, J. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13319 · Cited by 2
Claesen, K., Roth, L., Mertens, J. C., Hermans, K., Sim, Y., & Hendriks, D. F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101731 · Cited by 2
Perioperative Statin Reloading in Cardiac Surgery: A Review
Zhang, C., & Zhang, C. (2020) · doi:10.31487/j.hcs.2020.01.01 · Cited by 1
Behadori, R., Dodangeh, S., Nabavi, S. A., & Allami, A. (2022) · Journal of Inflammatory Diseases · doi:10.32598/jid.26.2.8 · Cited by 1
Yaputra, D. M., Wibowo, Y. I., Aditama, L., Brata, C., & Irawati, S. (2023) · MPI (Media Pharmaceutica Indonesiana) · doi:10.24123/mpi.v5i1.5494 · Cited by 1
Oh, E. Y., Haam, C. E., Choi, S., Byeon, S., Choi, S. K., & Lee, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813992 · Cited by 1
PCSK9 Antagonists: Clinical Efficacy and Main Trends in the Development of New Medicines
Nekipelova, A. A., & Alyautdin, R. N. (2023) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2023-11-3-279-291 · Cited by 1
Yoo, T. K., Han, K., Rhee, E., & Lee, W. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0443 · Cited by 1
Kirichenko, T. V., Yudina, I. Y., Лукина, М. В., Андрущишина, Т. Б., Zhivodernikov, I. V., & Markina, Y. V. (2024) · Russian Journal of Immunology · doi:10.46235/1028-7221-16757-teo · Cited by 1
Management of cardiometabolic diseases: A clinician's perspective
Bassi, N. S., Mohan, P., & Itchhaporia, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95469-3.00002-4 · Cited by 1
Statin Use in Women: Unique Aspects over the Lifespan
Myerson, M. (2024) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-024-00757-2
Habib, M. (2024) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad/195767 · Cited by 1
Slowing Thoracic Aortic Aneurysm Growth with Statins: A Meta-Analysis
Kolimas, A., Malla, G., Chadha, A., Sainbayar, E., Sethi, J., Hindosh, Z., Hadvani, P., Pham, H. N., & Sordia, J. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x343512250127075044 · Cited by 1
Biochanin‑A as SIRT‑1 modulator in preventing statin‑associated diabetogenesis: An in vitro study
Anuranjana, P. V., Divya, K. P., Beegum, F., George, K. T., Kanwal, A., Shenoy, R. R., & Nandakumar, K. (2025) · Biomedical Reports · doi:10.3892/br.2025.1969 · Cited by 1
Elkholy, M., Akkawi, M., Kidess, G. G., Alsharif, H., Jimale, M., KHAN, A. R., Bahar, Y., AlJaroudi, W. A., Elgendy, I. Y., & Alraies, M. C. (2025) · Cureus · doi:10.7759/cureus.81795 · Cited by 1
Lu, S., Liu, Q., Fan, Y., Zhang, Z., Shi, L., Li, X., Mu, W., Jiang, Q., & Yan, B. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.4.26 · Cited by 1
Gupta, R., Dwivedi, P., Sharma, K. K., Sharma, S., Makkar, J. S., Kasliwal, A., Natani, V., Khedar, R. S., Sharma, S. K., & Guptha, S. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.100999 · Cited by 1
Toledo, D., Cartanyà‐Hueso, À., Morros, R., Giner‐Soriano, M., Domı́nguez, Á., Vilaplana-Carnerero, C., & Grau, M. (2025) · Biomedicines · doi:10.3390/biomedicines13061438 · Cited by 1
Impact of statin treatment on postoperative atrial fibrillation in surgical aortic valve replacement
Krasniqi, L., Skovbo, J. S., Hallas, J., Brandes, A., Mortensen, P. E., Gerke, O., Ravn, E. J., Poulsen, V., Modrau, I. S., Müllertz, K. M., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.06.005 · Cited by 1
Li, X. C., Li, X., Zhu, X., Xin, X., Sheng, R., Wang, T., Kan, J.-M., & Huang, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1582661 · Cited by 1
Ma, Y., Ma, J., Lü, D., Yang, Y., Liu, C., Wang, L., Zhu, X., Li, X., Cheng, C., Zhang, S., et al. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003729 · Cited by 1
Head, R. J., Islam, S., & Martin, J. H. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70158 · Cited by 1
Tang, D., Huang, Z., Li, S., & Chen, F. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70542 · Cited by 1
Simvastatin inhibits 20-Hydroxyeicosatetraenoic acid formation: docking and in vitro assay
Jarrar, Y. B., Almansour, M. I., Ahmad, M. A.-S., Al-Najjar, B. O., Al-Doaiss, A. A., Shilbayeh, S. A. R., & Lee, S. (2025) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-00976-2 · Cited by 1
Wang, L., & Wang, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334822 · Cited by 1
The Effect of Statins on Bleeding in Isolated Coronary Artery Bypass Grafting Statins in CABG
Karaarslan, M., Beyazal, O. F., Kayalar, N., & Yanartaş, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238402 · Cited by 1
Kalkan, K., Tanık, V. O., Kardeşler, B., Köprücü, E., Çolak, G., Eriş, E., Kırmızıgül, M., güzel, H. C., Baştuğ, S., Durmaz, T., et al. (2026) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02836-9 · Cited by 1
Ding, M., Liu, Y., Zhang, Y., & Qiu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1693342 · Cited by 1
Management of metabolic dysfunction and cardiovascular risk in patients with MASLD
Danpanichkul, P., Blaney, H. L., Perelli, J., Huerta, P., Idalsoaga, F. J., Arrese, M. A., Arab, J. P., Loomba, R. S., & Díaz, L. A. (2026) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.32 · Cited by 1
Spezzano, K. M., Emery, D. P., & Singlar, M. M. (2026) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxag020 · Cited by 1
Heo, J. H., Go, T., & Kang, D. R. (2026) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2026.15.1.88 · Cited by 1
Zhang, J., Zhou, S., Zhang, H., & Liu, J. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70249 · Cited by 1
Dyslipidemia in Diabetes: Navigating a Complex Landscape for Improved Cardiovascular Outcomes
Wahab, R. A., & Mahmood, W. A. W. (2026) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514261422310 · Cited by 2
Thermo-responsive co-delivery of therapeutic drug and Gasotransmitter for treating atherosclerosis
Xie, Y., Chi, M., Dong, R., Hu, Q., Zeng, Z., Fan, L., Zhang, Y., Sun, H., Fa, Y., & Weng, Y. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.175281 · Cited by 1
Song, Y., Cao, X., Zhang, H., Tian, X., Hua, H., Ferdous, M., Zhang, J., & Zhao, P. (2026) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-026-03437-w · Cited by 1
Pathophysiology and pharmacotherapy of cardiovascular complications in metabolic syndrome
Dhalla, N. S., Patel, C. A., Beladiya, J., Mehta, A. A., & Gandhi, T. R. (2026) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2026.04.007 · Cited by 1
Simvastatin attenuates endothelial dysfunction in a coronary artery-on-a-chip
Singh, J., Ashok, D., Howard, H., Wise, S. G., & Waterhouse, A. (2026) · Biomaterials Science · doi:10.1039/d6bm00327c · Cited by 1
Fujii, R., Tsuboi, Y., Cárdenas, A., Okuzono, S. S., Valeri, L., Yamada, H., Yamazaki, M., Okumiyama, H., Murakami, K., Umematsu, R., et al. (2026) · Environmental Research · doi:10.1016/j.envres.2026.124600 · Cited by 1
Nitric oxide redox signaling as a convergent mechanism in aging and fibrosis
Guo, X., Cao, Y., Liu, L., Peng, Y., Du, Y., Yang, F., & Huang, D. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103156 · Cited by 1
Hafez, A. H., Farina, J., Awad, K., Pereyra, M., Scalia, I. G., Sheashaa, H., Abdelfattah, F. E., Razaghi, M., Ahmed, S., Ibrahim, R., et al. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16050254 · Cited by 2
Discontinuation of statin therapy – an updated review
Orfanos, E., Byun, J. H., & Daskalopoulou, S. S. (2026) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001316 · Cited by 1
Atherosclerosis and dementia - causal aspects and preventive potential
Rasmussen, I. J., Luo, J., Rasmussen, K. L., Kjeldsen, E. W., Schneider, L. S., Sandau, N., Thomassen, J. Q., & Frikke‐Schmidt, R. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120745 · Cited by 2
Fathima, F. (2026) · Journal of Prevention Diagnosis and Management of Human Diseases · doi:10.55529/jpdmhd.61.26.39 · Cited by 1
Myśliwiec, A., Leksa, D., Bartusik‐Aebisher, D., & Aebisher, D. (2026) · Journal of Applied Biomedicine · doi:10.32725/jab.2026.007 · Cited by 1
Rahman, M. A., Haque, M. A., Koka, S., & Boini, K. M. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119610 · Cited by 2
Abramov, D., Minhas, A. M. K., Shapiro, M. D., Bittner, V., Brewer, L. C., Gianos, E., Mora, S., Mehta, L. S., Kulkarni, A., Kalra, D. K., et al. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01437-9 · Cited by 1
Xie, S., Galimberti, F., Olmastroni, E., Catapano, A. L., & Casula, M. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104851 · Cited by 1
Cao, X., Deng, M., Hui, H., Hu, Y., Li, B., & Dong, L. (2026) · Current Treatment Options in Oncology · doi:10.1007/s11864-026-01398-w · Cited by 1
Safety Profile of Statins: An Umbrella Review of Systematic Reviews and Meta-analyses
Penedones, A., Mendes, D., Lopes, A. R., Oliveira, T., Alves, C., & Filipe, A. (2026) · European Cardiology Review · doi:10.15420/ecr.2026.03 · Cited by 1
Jiménez-González, C., Iruzubieta, P., Alonso‐Peña, M., Cayon, L., & Crespo, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1884657 · Cited by 1
Statine als Therapie bei Lebererkrankungen?
Sauerbruch, T., Schierwagen, R., & Trebicka, J. (2017) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-114682 · Cited by 1
ŞAHİN, Ö. (2019) · Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi · doi:10.31020/mutftd.650069 · Cited by 1
Prevalence of lipid-lowering drug use
Machado‐Duque, M. E., Gaviria‐Mendoza, A., & Machado‐Alba, J. E. (2021) · Revista Colombiana de Cardiología · doi:10.24875/rccar.m21000003 · Cited by 1
Synthesis and biological evaluation of novel β-cyclodextrin-fluvastatin conjugates
Nicolosi, M., Bellia, F., Giuffrida, M. L., Zimbone, S., Oliveri, V., & Vecchio, G. (2021) · Results in Chemistry · doi:10.1016/j.rechem.2021.100230 · Cited by 1
Khlynova, O. V., Novikova, I. A., Александровна, Н. Л., & Karpunina, N. S. (2021) · Актуальные проблемы медицины · doi:10.52575/2687-0940-2021-44-3-319-331 · Cited by 1
Clinically Administered Doses of Pitavastatin and Rosuvastatin
Katanasaka, Y., Hirano, S., Sunagawa, Y., Miyazaki, Y., Sato, H., Funamoto, M., Shimizu, K., Shimizu, S., Sari, N., Hasegawa, K., et al. (2021) · International Heart Journal · doi:10.1536/ihj.21-231 · Cited by 1
Dadon, Z., Moriel, M., Iakobishvili, Z., Asher, E., Samuel, T. Y., Gavish, D., Glikson, M., & Gottlieb, S. (2021) · Life · doi:10.3390/life11111268 · Cited by 1
(2020) · Journal of Diabetes and Endocrinology Research · doi:10.47485/2693-2458/1018 · Cited by 1
Galili, O. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821451-0.00010-0 · Cited by 1
Kim, B.-J., Lee, J.-H., Park, J.-I., Nam, J.-H., Lee, C.-H., Son, J.-W., Kim, U., Shin, D.-G., & Park, J.-S. (2022) · Coronary Artery Disease · doi:10.1097/mca.0000000000001138 · Cited by 1
Burdeyna, O. (2022) · Ukrainian Journal of Nephrology and Dialysis · doi:10.31450/ukrjnd.1(73).2022.08 · Cited by 1
Efremov, Y. M., Ermolaeva, A. V., Vladimirov, G., Gordleeva, S., Svistunov, A. А., Zaikin, A. A., & Timashev, P. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264903 · Cited by 1
MODERN IDEAS ABOUT THE EFFECT OF STATINS ON ATHEROSCLEROTIC PLAQUE
Chaulin, A. M., Александрович, В. В., & Grigoreva, Y. V. (2022) · Современные проблемы науки и образования · doi:10.17513/spno.31789 · Cited by 1
Research Progress on the Correlation between Psoriasis and Glucose and Lipid Metabolism
刘, 梦. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.123289 · Cited by 1
Statistical methods for assessing drug interactions using observational data
Xu, Q., Antimisiaris, D. E., & Kong, M. (2022) · Journal of Applied Statistics · doi:10.1080/02664763.2022.2123460 · Cited by 2
Abdelghafar, A., Mohyeldin, M., Haroon, O. S., Mohamed, F. O., & Alazm, M. A. (2022) · Cureus · doi:10.7759/cureus.30549 · Cited by 1
An Efficient Enantioselective Total Synthesis of Atorvastatin Calcium
Shree, A. J., Vempala, N., Narra, S. R., & Dasgupta, S. (2022) · Synlett · doi:10.1055/a-1970-8386 · Cited by 1
Statin Therapy for The Primary Prevention of Cardiovascular Disease: Pros
Laksono, S., Umami, F., Nurusshofa, Z., & Mustifah, E. F. (2022) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v12i5-s.5728 · Cited by 1
Xu, W., Zhang, Z., Cui, J. G., & Jiang, Y. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103941 · Cited by 1
Statins and COVID-19 (Mechanism of Action, Effect on Prognosis)
Lewek, J., Surma, S., & Banach, M. (2022) · Contemporary cardiology · doi:10.1007/978-3-031-15478-2_17 · Cited by 1
Salyamova, L. I., Анатольевна, Х. А., Kvasova, O. G., Avdeeva, I. V., Борисова, Н. А., Korenkova, K., Polezhaeva, K., & Oleynikov, V. E. (2023) · Terapevticheskii arkhiv · doi:10.26442/00403660.2022.12.202007 · Cited by 1
Statin therapy enhances vascular health through epigenetic mechanisms
(2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00274-2 · Cited by 1
High-Dose Statins in Preventing Microvascular Obstruction: “The Devil Lies in the Details”
Laborante, R., Bianchini, E., Borovac, J. A., & D’Amario, D. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.08.047 · Cited by 1
Qiao, Z., Wang, F., Han, D., Zhuang, Y., Jiang, Q., Zhang, Y., Liu, M., An, Q., Wang, Z., & Shen, D. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106610 · Cited by 1
Lipid lowering therapy: implications of recent clinical trials
Backes, J. M., & Hilleman, D. E. (2024) · Future Cardiology · doi:10.2217/fca-2023-0132 · Cited by 2
Effect of Statins on Patients With Osteoradionecrosis of the Jaw
Kusumoto, J., Muraki, Y., Sakakibara, A., Furudoi, S., & Akashi, M. (2024) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2024.08.002 · Cited by 1
Rafsanjani, K., Raeini, A. G., Azarboo, A., & Parsa, S. (2024) · Journal of Investigative Medicine · doi:10.1177/10815589241279008 · Cited by 1
Vikulova, D. N., Lee, M. K., Humphries, K. H., Pinheiro-Muller, D., Dawes, M. G., Pimstone, S. N., & Brunham, L. R. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101316 · Cited by 1
Kim, H., Kwon, S., Joh, H. S., Lim, W., Seo, J., Kim, S., Zo, J., & Kim, M. (2024) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2024.10.005 · Cited by 1
Jiang, Q., Feng, B., Zhao, Y., Xiangyi, R., Dong, C., Zhou, R., Yang, S., & Gan, W. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120206 · Cited by 1
Dilemmas in Secondary Stroke Prevention
Vu, S., Mahmoud, N. A., Sivakumar, S., Yazdanian, F., & Fisher, M. (2025) · Stroke · doi:10.1161/strokeaha.124.050403 · Cited by 1
Lian, Z., Liang, Z., Chen, Q., Xie, C., & Kong, Y. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2491657 · Cited by 1
Stepanova, N., Ostapenko, T., Marchenko, V., Holovanova, A., Lysii, M., Kucher, T., Filonov, V., Dzhur, V., Stetsenko, B., Moroid, H., et al. (2025) · Ukrainian Journal of Nephrology and Dialysis · doi:10.31450/ukrjnd.2(86).2025.03 · Cited by 1
Roh, J. W., Park, M.-H., Son, J.-W., Bae, S., & the HM-ROS-OS-2102 Study Investigator Group (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01482-3 · Cited by 1
Chen, K.-S., Chan, H.-C., & Chan, C.-M. (2025) · International Journal of Retina and Vitreous · doi:10.1186/s40942-025-00724-y · Cited by 2
Therapieoptionen von Fettstoffwechselstörungen
Berent, R., Berent, T., & Sinzinger, H. F. (2017) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-017-0594-y · Cited by 1
Канорский, С. Г., & Sereda, A. F. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-20-26-31 · Cited by 1
Use of simvastatin in the prevention of cyclophosphamide-induced ureteral mucositis
Maia, B. S. D. S., Celani, L. M. S., Moreira, M. D. F. D. C., Araújo-Filho, I., & Medeiros, A. C. (2018) · JOURNAL OF SURGICAL AND CLINICAL RESEARCH · doi:10.20398/jscr.v8i2.14302 · Cited by 1
Metadata
- Authors
- Oesterle, A., Laufs, U., & Liao, J. K.
- Affiliations
- University of Chicago (US)
- Venue
- Circulation Research
- Published
- 2017-01-06
- Volume
- 120
- Issue
- 1
- Pages
- 229-243
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC5467317
- OpenAlex
- W2570787279
- Semantic Scholar
- a6f953b7ad2110e4c1c93c3e33f8539676113484
- Cited by
- 1,247
- References
- 201
- Citations by year
- 2026: 120 · 2025: 136 · 2024: 144 · 2023: 142 · 2022: 159 · 2021: 177 · 2020: 150 · 2019: 100 · 2018: 79 · 2017: 37
- FWCI
- 21.24
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-09-27)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL136962, R01HL052233)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- statins, pleiotropy, cardioprotection, Rho kinase, NADPH oxidase, endothelial nitric oxide synthase, prenylation, atherosclerotic plaque stability, inflammation, platelet reactivity, cardiac hypertrophy, fibrosis, LDL cholesterol lowering
- MeSH terms
- Animals, Cardiovascular Diseases, Cardiovascular System, Clinical Trials as Topic, Humans, Cholesterol, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Genetic Pleiotropy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
